feed,title,long_url,short_url
RS,One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model,https://www.researchsquare.com/article/rs-269242/latest,https://j.mp/3kXXedA
RS,Experience of COVID-19 Vaccination of Healthcare Workers in a Hospital Setting,https://www.researchsquare.com/article/rs-257937/latest,https://j.mp/2OESxJB
